Compare Cronos Group Inc (CRON) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs CarMax, Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while CarMax, Inc trades at $54 (market cap $7.64B). The key difference: CarMax, Inc is far larger — about 6.5× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (968,037 versus 3,610,116). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and CarMax, Inc for 49 Days on average.
| CRON | KMX | |
|---|---|---|
Market Cap | $1.18B | $7.64B |
Volume | 968,037 | 3,610,116 |
Sector | Health | Consumer Cyclical |
52-Week High | $3.55 | $64.22 |
52-Week Low | $2.30 | $30.88 |
Typical Hold Time | 22 Days | 49 Days |
Enterprise Value | $387.62M | $25.34B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
CarMax (KMX) trades at $53.28, down 3.64% amid a bearish technical signal, though recent Q2 2027 earnings beat estimates with EPS of $1.16 versus $0.732 expected. The company reported 19.5% revenue growth to $7.9 billion, driven by strong unit sales and cost control. Analyst consensus is mixed with 29.73% buy ratings and a $58.89 price target, while technical indicators show support at $52-$53 and resistance at $54.
The outlook is cautiously optimistic as CarMax's turnaround strategy shows early traction, but high debt levels and thin net margins near 1% pose risks. Near-term catalysts include the November strategic update, though macroeconomic pressures on consumer spending could challenge sustained growth. The stock offers value with a P/S of 0.28, but investors should monitor execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
